Furthermore, B cells and other CD11b+ tumor-infiltrating host APCs can recognize tumor-derived STING-activating components, releasing STING-mediated type I IFN induced by leukocytes and cytotoxic NK cells’ priming for tumor cell elimination [83]. The gene discussed is STING1; the disease is neoplasm.